UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 715

Sortiert nach

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet neurology, 2014-10, Vol.13 (10), p.977-986

2014

Link zum Volltext

Verfügbarkeit prüfen

Greater high-mobility group box 1 in male compared with female spontaneously hypertensive rats worsens renal ischemia-reperfusion injury

Clinical science (1979), 2020-07, Vol.134 (13), p.1751

2020

Link zum Volltext

Verfügbarkeit prüfen

Necrosis Contributes to the Development of Hypertension in Male, but Not Female, Spontaneously Hypertensive Rats

Hypertension (Dallas, Tex. 1979), 2019-12, Vol.74 (6), p.1524-1531

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

Lancet neurology, 2009-03, Vol.8 (3), p.254-260

2009

Link zum Volltext

Verfügbarkeit prüfen

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

The New England journal of medicine, 2010-02, Vol.362 (5), p.387-401

2010

Link zum Volltext

Verfügbarkeit prüfen

Identification of novel macropinocytosis inhibitors using a rational screen of Food and Drug Administration‐approved drugs

British journal of pharmacology, 2018-09, Vol.175 (18), p.3640-3655

2018

Link zum Volltext

Verfügbarkeit prüfen

Physiological and performance responses of sprint interval training and endurance training in Gaelic football players

European journal of applied physiology, 2021-08, Vol.121 (8), p.2265-2275

2021

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

The New England journal of medicine, 2006-03, Vol.354 (9), p.899-910

2006

Link zum Volltext

Verfügbarkeit prüfen

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet neurology, 2014-03, Vol.13 (3), p.247-256

2014

Link zum Volltext

Verfügbarkeit prüfen

Vasa recta pericyte density is negatively associated with vascular congestion in the renal medulla following ischemia reperfusion in rats

American journal of physiology. Renal physiology, 2017-11, Vol.313 (5), p.F1097-F1105

2017

Link zum Volltext

Verfügbarkeit prüfen

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2010-05, Vol.74 (18), p.1463

2010

Link zum Volltext

Verfügbarkeit prüfen

Persistent vascular congestion in male spontaneously hypertensive rats contributes to delayed recovery of renal function following renal ischemia perfusion compared with females

Clinical science (1979), 2022-06, Vol.136 (11), p.825

2022

Link zum Volltext

Verfügbarkeit prüfen

IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced Hypertension in Mice

Hypertension (Dallas, Tex. 1979), 2021-11, Vol.78 (5), p.1296-1309

2021

Link zum Volltext

Verfügbarkeit prüfen

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

The Lancet (British edition), 2011-11, Vol.378 (9805), p.1779-1787

2011

Link zum Volltext

Verfügbarkeit prüfen

A radical approach to balancing the tides of tubular flow

American journal of physiology. Renal physiology, 2014-10, Vol.307 (8), p.F917-F918

O'Connor, Paul M

2014

Link zum Volltext

Verfügbarkeit prüfen

Initiation and Progression of Chronic Kidney Disease: Can We Definitively Test the Chronic Hypoxia Hypothesis?

Hypertension (Dallas, Tex. 1979), 2013-11, Vol.62 (5), p.827-828

2013

Link zum Volltext

Verfügbarkeit prüfen

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Lancet neurology, 2012-05, Vol.11 (5), p.420-428

2012

Link zum Volltext

Verfügbarkeit prüfen

Chronic ANG II infusion induces sex-specific increases in renal T cells in Sprague-Dawley rats

American journal of physiology. Renal physiology, 2015-04, Vol.308 (7), p.F706-F712

2015

Link zum Volltext

Verfügbarkeit prüfen

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

The New England journal of medicine, 2003-01, Vol.348 (1), p.15-23

2003

Link zum Volltext

Verfügbarkeit prüfen

Brown-Norway chromosome 1 mitigates the upregulation of proinflammatory pathways in mTAL cells and subsequent age-related CKD in Dahl SS/JrHsdMcwi rats

American journal of physiology. Renal physiology, 2023-02, Vol.324 (2), p.F193-F210

2023

Link zum Volltext

Verfügbarkeit prüfen

Adherence to Multiple Sclerosis Disease-Modifying Therapies in Ontario is Low

Canadian journal of neurological sciences, 2011-05, Vol.38 (3), p.429-433

2011

Link zum Volltext

Verfügbarkeit prüfen

High-salt diet blunts renal autoregulation by a reactive oxygen species-dependent mechanism

American journal of physiology. Renal physiology, 2014-07, Vol.307 (1), p.F33-F40

2014

Link zum Volltext

Verfügbarkeit prüfen

Medullary Thick Ascending Limb Buffer Vasoconstriction of Renal Outer-Medullary Vasa Recta in Salt-Resistant But Not Salt-Sensitive Rats

Hypertension (Dallas, Tex. 1979), 2012-10, Vol.60 (4), p.965-972

2012

Link zum Volltext

Verfügbarkeit prüfen

Factors that render the kidney susceptible to tissue hypoxia in hypoxemia

American journal of physiology. Regulatory, integrative and comparative physiology, 2011-04, Vol.300 (4), p.R931-R940

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 715

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(672)
Mit Volltextzugriff
(608)

Publikationsform

Artikel
(715)

Sprache

Englisch
(715)
Japanisch
(106)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(658)
Life Sciences & Biomedicine
(638)
Humans
(632)
Female
(573)
Middle Aged
(361)
Adult
(358)
Aged
(286)
Biological And Medical Sciences
(253)
Medical Sciences
(235)
Treatment Outcome
(122)
Adolescent
(119)
Animals
(110)
Young Adult
(108)
Cardiovascular System & Cardiology
(107)
Neurosciences & Neurology
(107)
Aged, 80 And Over
(95)
General & Internal Medicine
(90)
Cardiac & Cardiovascular Systems
(89)
Clinical Neurology
(86)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

Greater high-mobility group box 1 in male compared with female spontaneously hypertensive rats worsens renal ischemia-reperfusion injury

Necrosis Contributes to the Development of Hypertension in Male, but Not Female, Spontaneously Hypertensive Rats

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Identification of novel macropinocytosis inhibitors using a rational screen of Food and Drug Administration‐approved drugs

Physiological and performance responses of sprint interval training and endurance training in Gaelic football players

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Vasa recta pericyte density is negatively associated with vascular congestion in the renal medulla following ischemia reperfusion in rats

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Persistent vascular congestion in male spontaneously hypertensive rats contributes to delayed recovery of renal function following renal ischemia perfusion compared with females

IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced Hypertension in Mice

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

A radical approach to balancing the tides of tubular flow

Initiation and Progression of Chronic Kidney Disease: Can We Definitively Test the Chronic Hypoxia Hypothesis?

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Chronic ANG II infusion induces sex-specific increases in renal T cells in Sprague-Dawley rats

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Brown-Norway chromosome 1 mitigates the upregulation of proinflammatory pathways in mTAL cells and subsequent age-related CKD in Dahl SS/JrHsdMcwi rats

Adherence to Multiple Sclerosis Disease-Modifying Therapies in Ontario is Low

High-salt diet blunts renal autoregulation by a reactive oxygen species-dependent mechanism

Medullary Thick Ascending Limb Buffer Vasoconstriction of Renal Outer-Medullary Vasa Recta in Salt-Resistant But Not Salt-Sensitive Rats

Factors that render the kidney susceptible to tissue hypoxia in hypoxemia

Aktive Filter

Suchergebnisse filtern